Research On The Impact Of China’s Basic Medical Insurance System On Medical Technology Innovation

Policy practice and research in developed countries show that the medical insurance system will promote medical technology innovation.Judging from my country’s policy practice and existing research,my country’s policy and theoretical research mostly focuses on the balance of medical insurance funds,controlling medical expenses,and reducing drug prices.Few documents have noticed that my country’s basic medical insurance system is in the process of medical technology innovation.Played a role.In the context of my country’s innovation-driven development strategy and the construction of an innovative country,scientific evaluation of the impact of the basic medical insurance system on medical technology innovation has strong practical and theoretical significance.By summarizing and summarizing existing related literature,this paper combs the theory of technological innovation on the basis of defining the basic medical insurance system and the concept of medical technology innovation,studies the characteristics of the medical industry,and summarizes the policy practice of medical insurance to support medical technology innovation.Combined with the stage of medical technology innovation in my country,it focuses on the theoretical mechanism of the medical insurance system’s influence on medical technology innovation,and establishes a hypothesis to describe the functional relationship between the medical insurance system and medical technology innovation by constructing a mathematical model.Based on the above analysis,starting from the empirical facts of my country’s basic medical insurance system and medical technology innovation,using the panel data of 24 diseases from 1993 to 2006 and the data of 507 listed pharmaceutical companies from 2008 to 2019,and constructing a measurement model,combined with The loose distribution regression method,OLS method,GMM estimation and other quantitative analysis methods have empirically tested the impact of the medical insurance system on medical technology innovation in stages,and based on the conclusions drawn,put forward a number of targeted policy recommendations.The main conclusions of this paper: First,whether in the stage of imitating innovation or independent innovation,the urban employee medical insurance system has significantly promoted the improvement of medical technology innovation,and this effect has disease heterogeneity in the stage of imitating innovation;second,in the stage of imitating innovation;In the stage of medical technology imitating innovation in my country,the urban employee medical insurance system mainly raises the level of medical technology innovation by expanding market demand,while in the independent innovation stage of my country’s medical technology,the urban employee medical insurance system mainly promotes the level of medical technology innovation by promoting market competition;Third,in the stage of imitation and innovation,the adjustment of the medical insurance catalogue and major epidemics have a significant moderating effect in the process of urban employee medical insurance affecting medical technology innovation,and the adjustment of the medical insurance catalogue has a significant effect on the relationship between urban employee medical insurance and medical technology innovation.There is disease heterogeneity in the regulation effect of the disease.Based on this,the following policy recommendations are put forward: First,establish my country’s pharmacoeconomics evaluation system,and use it as an evaluation standard for the selection of patented drug medical insurance,improve social welfare,and promote the high-quality development of the pharmaceutical industry;second,start from innovative drug medical insurance From the perspective of access,establish an access model for innovative drugs and medical insurance classification negotiations that suits my country’s actual conditions;third,improve the dynamic adjustment mechanism of the medical insurance catalog by optimizing the adjustment cycle of the medical insurance catalog,the declaration system for medical insurance admission enterprises,and the principles of medical insurance adjustment;fourth;,From the three dimensions of clinical value,economic value and social value,set up different payment systems for different grades of innovative drugs,and establish a tiered payment system for innovative drugs.